• By ICR Secretariat
  • Posted Tuesday, October 1, 2019

NHS will not pay for 'life-changing' migraine drug


A migraine drug that has been described as "life changing" by some patients will not be made available on the NHS outside of Scotland.

Erenumab - also known by the name Aimovig - is one of the first bespoke migraine drugs in decades and has been described by doctors as a "huge deal".